The India neurology device market size was valued at $230 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.80% from 2022 to 2030 and will reach $521 Mn in 2030. The neurology device market in India is expected to grow in the coming years due to factors such as the increasing prevalence of neurological disorders, the availability of new technologies, and the growing healthcare expenditure in the country. The market is segmented by type of device and end user. The key players in the markets are B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, and Nihon Kohden Corporation.
Indian Neurology Device Market Report 2022 to 2030
1. Indian Neurology
Devices Market
Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030F)
2. This report presents a strategic analysis of the Indian Neurology Device
market and a forecast for its development in the medium and long term. It
provides a comprehensive overview of the market value, dynamics,
segmentation, characteristics, main players, trends and insights, growth
and demand drivers, challenges & future outlook, etc. This is one of the
most comprehensive reports about the Indian Neurology Device market,
and offers unmatched value, accuracy, and expert insights
4. 4
4 A Sample Report on Indian Neurology Devices Market I Confidential
Table of Contents
1. Indian neurology devices market overview………………………..………………………………………….……………………………….,,,7
1.1 Market size and forecast
2. Market growth drivers and restraints …………………………………………………………………..….……………………………………9
2.1 Market growth Drivers
2.1.1 Increase in prevalence of neurological disorders
2.1.2 Increase in R&D in the field of neurotherapies
2.1.3 Rise in the aging population
2.2 Market Restrains
2.2.1 High procedural cost of neurovascular surgeries and related products
2.2.2 Stringent regulations
3. Indian neurology disease market by prevalence.……..………………………………….…………………………………………........….15
3.1 Stroke
3.2 Brain Injury
3.3 Epilepsy
3.4 Spinal Cord Injury
3.5 Alzheimer’s disease or other dementias
5. 5
5 A Sample Report on Indian Neurology Devices Market I Confidential
Table of Contents (continued)
4. Neurology device market segmentation……………………………………….…………....………………....…………………........……….18
4.1 By product type
4.2 By pathology
4.3 By end user
5. Major products market share……………………………………………………….………………...…….……………………………..………23
5.1 Market analysis, insights and forecast - By revenue
6. Competitive Landscape…………………………………………………………………………………………………….…………………...….25
6.1 Major players
7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….………………………………….…........27
7.1 Medtronic Plc
7.2 Stryker Corp
7.3 Braun Melsungen AG
7.4 Boston Scientific
7.5 Abbott Laboratories
6. 6
6 A Sample Report on Indian Neurology Devices Market I Confidential
Table of Contents (continued)
8. Healthcare policies and regulatory landscape………………………………….………………………………………………………………33
8.1 Policy changes and Reimbursement scenario
9. Factors driving future growth…………………………………………………………………………………………….………………………..35
9.1 Future opportunities
10. Conclusion…………………………………………..…………………………………………………………………………..………..……..…..37
8. 8 A Sample Report on Indian Neurology Devices Market I Confidential
1.1 Indian Neurology Devices market analysis
(Current and Forecast)
Indian Neurology Devices Market Size (Bn)
2021-2030F
Key Analysis
$xx
xx
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
▪ Indian neurology device market size stood at around US$ XX Bn in
2022 and is projected to reach US$ XX Bn by 2030, exhibiting a
CAGR of 7.1% during the forecast period
▪ The increasing healthcare spending, increasing investment by
medical device manufacturers, and increasing neurological
disease prevalence is expected to drive the overall Neurology
devices market growth in India
▪ It is estimated that 30 Mn Indians suffer from serious neurological
disorders a year. The most common include epilepsy at 6-8 Mn
people, strokes at 1-2 Mn people and headaches at 10-12 Mn
people
▪ Increasing rate of neurological disorders prevalence with around
10 Mn people with epilepsy and high fatality rates of stroke has
given rise to product demand
Sample
10. 10 A Sample Report on Indian Neurology Devices Market I Confidential
2. Market Growth Drivers and Restrains
Increase in prevalence of
neurological disorders
Rise in the aging population
Increase in R&D in the field
of neurotherapies
High procedural cost of neurovascular
surgeries and related products
Stringent regulations
11. 11 A Sample Report on Indian Neurology Devices Market I Confidential
2.1 Market Growth Drivers
The prevalence of neurological disorder estimates in India for 2019 range from 3·0 to 11·9 per 1000 of the population
and incidence from 0·2 to 0·6 per 1000 of the population per year, with a major contribution from the rural population
Sample
2.1.1 Increase in prevalence of neurological disorders
In India neurological disorders, both fatal and non-fatal, are among the leading contributors to the burden of non-
communicable and communicable diseases in India. Hence demand for neurology device market will increase during
the forecast period
12. 12 A Sample Report on Indian Neurology Devices Market I Confidential
Market Growth Drivers (continued)
2.1.2 Increase in R&D in the field of neurotherapies
Neurosurgeons and medical professionals are increasingly looking at therapeutic alternatives that can effectively
reduce the risk of fatality or severity of neurovascular diseases in patient
Sample
With a growing number of patients suffering from neurovascular diseases (such as epilepsy, brain stroke, and
cerebral aneurysm) and rising severity of medical conditions (such as hemorrhage and local infections) in target
patients, the demand for effective neurovascular treatments is continuously rising across key in India
13. 13 A Sample Report on Indian Neurology Devices Market I Confidential
Market Growth Drivers (continued)
2.1.3 Rise in the aging population
The burden of non-communicable neurological disorders is increasing in India mainly due to ageing of the population
Sample
Neurological diseases are frequent in older adults, affecting between 5% and 55% of people age 55 and older. They
are associated with a high risk for adverse health outcomes, including mortality, disability, institutionalization and
hospitalization, which further propelling the neurology device market in India
14. 14 A Sample Report on Indian Neurology Devices Market I Confidential
2.2 Market Restraints
2.2.1 High procedural cost of neurovascular
surgeries and related products
2.2.2 Stringent regulations
Sample
▪ Several key neurovascular device manufacturers
have been successful in the development and
subsequent commercialization of their respective
products during the last decade
▪ These products were primarily intended for
interventional use during neurovascular
surgeries
▪ The high cost of neurovascular surgical
procedures and devices is a major factor
restraining the global neurovascular devices
market, especially in developing countries
with poor reimbursement policies
▪ Maintenance costs and other associated
indirect expenses increase the total cost of
ownership of these devices, thereby limiting
their adoption
▪ Small hospitals and standalone ASCs are
less inclined to invest in costly and
sophisticated technologies due to budgetary
constraints; this is more prominent in
developing countries
Sample
16. 16
16 A Sample Report on Indian Neurology Devices Market I Confidential
3.1 Stroke
▪ Stroke is one of the leading causes of
death and disability in India
▪ The estimated adjusted prevalence
rate of stroke range, 84-262/100,000 in
rural and 334-424/100,000 in urban
areas
▪ The incidence rate is 119-145/100,000
based on the recent population based
studies
3.2 Brain Injury
▪ Traumatic brain injuries (TBIs) are a
leading cause of morbidity, mortality,
disability and socioeconomic losses in
India
▪ It is estimated that nearly 1.5 to 2 million
persons are injured and 1 million
succumb to death every year in India.
Road traffic injuries are the leading
cause (60%) of TBIs followed by falls
(20%-25%) and violence (10%)
3.3 Epilepsy
▪ It is estimated that there are more
than 10 million persons with epilepsy
(PWE) in India. Its prevalence is
about 1% in our population
Sample
Indian Neurology Device Market By Prevalence
17. 17
17 A Sample Report on Indian Neurology Devices Market I Confidential
Indian Neurology Device Market By Prevalence (continued)
3.4 Spinal Cord injury
Get the report for full access
3.5 Alzheimer’s disease or Other
Dementias
Get the report for full access
Sample
19. 19
19 A Sample Report on Indian Neurology Devices Market I Confidential
Indian Neurology Device Market Segmentation
Neurology Device Market Segmentation
By Product Type By Pathology By End-user
Aneurysm coiling &
embolization devices
Cerebral balloon angioplasty &
stenting systems
Support devices
Neuro thrombectomy devices
Ischemic strokes
Cerebral aneurysm
Carotid artery stenosis
Arteriovenous
malformations & fistulas
Hospitals & surgical centers
Ambulatory care centers
Research laboratories
Academic institutes
Others
20. 20
20 A Sample Report on Indian Neurology Devices Market I Confidential
4.1 Indian Neurology Device Market Segmentation: By Product Type
▪ The aneurysm coiling & embolization devices segment is
expected account for the largest share of the neurovascular
devices market during the forecast period
▪ The aneurysm coiling & embolization devices product
segment, by type, is further segmented into embolic coils, flow
diversion devices, and liquid embolic agents
▪ The aneurysm coiling & embolization devices segment is
estimated to account for the largest share of the neurology
market, by product, in 2021, owing to growing end-user
preference for minimally invasive neurosurgical procedures
and increasing market availability of embolic coils for
neurovascular treatment
Key Insights
Indian Neurology Device Market Share by Product Type
2022
Sample
Aneurysm coiling & embolization devices
Cerebral balloon angioplasty & stenting systems
Support devices
21. 21
21 A Sample Report on Indian Neurology Devices Market I Confidential
4.2 Indian Neurology Device Market Segmentation: By Pathology
▪ The cerebral aneurysm segment is estimated to account for
the largest share of the Indian neurology device market during
the forecast period
▪ The cerebral aneurysm segment is estimated to account for
the largest share of the Indian neurology device market, by
pathology, in 2021, led by the growing adoption of minimally
invasive neurosurgical procedures among neurosurgeons and
increasing incidence of risk factors (such as high blood
pressure, cigarette smoking, high cholesterol, diabetes, and
obesity)
Key Insights
Indian Neurology Device Market Share by By Pathology
2022
Sample
Ischemic strokes
Cerebral aneurysm
Carotid artery stenosis
Arteriovenous malformations & fistulas
Others
22. 22
22 A Sample Report on Indian Neurology Devices Market I Confidential
4.3 Indian neurology device market segmentation: By End user
▪ As of 2020, hospitals & surgical centers are estimated to
account for the largest share of the Indian market in 2021,
while ambulatory care centers are projected to register the
highest CAGR during the forecast period
▪ Growing patient preference for minimally invasive medical
procedures, rising number of ambulatory surgery centers
across developed countries, along with the ease of
scheduling, the focused clinical staff, the improved
productivity, and the increased safety, and efficacy of these
centers, are the major factors that are expected to drive the
growth of this end-user segment in the coming years
Key Insights
Indian neurology device Market Share by By End user
2022
Sample
Hospitals and Surgical centers Research Laboratories
Academic Institutes Ambulatory Care centers
24. 24 A Sample Report on Indian Neurology Devices Market I Confidential
5.1 Market Analysis, Insights and Forecast- By Major Brands
Key Insights
Market Analysis for Major Neurology Device B rands (2022)
Brand 1 Brand 2 Brand 3 Brand 4 Brand 5
Get full report for access
28. 28 A Sample Report on Indian Neurology Devices Market I Confidential
7.1 Medtronic Plc
Company Name: Medtronic Plc
Year of Establishment: 1949
Headquarter: Dublin, Ireland
Total Revenue: $XX Bn
Website: https://www.medtronic.com/
Company at a Glance
Company Overview
Sample
29. 29 A Sample Report on Indian Neurology Devices Market I Confidential
7.2 Stryker Corp
Company Name: Stryker Corp
Year of Establishment: 1941
Headquarter: Kalamazoo, Michigan, United
States
Total Revenue: $XX Bn
Website: http://www.stryker.com/
Company at a Glance
Company Overview
Sample
30. 30 A Sample Report on Indian Neurology Devices Market I Confidential
7.3 Braun Melsungen AG
Company Name: Braun Melsungen AG
Year of Establishment: 1839
Headquarter: Melsungen, Germany
Total Revenue: $XX Bn
Website: http://www.bbraun.com/
Company at a Glance
Company Overview
Sample
31. 31 A Sample Report on Indian Neurology Devices Market I Confidential
7.4 Boston Scientific
Company Name: Boston Scientific
Year of Establishment: 1979
Headquarter: Massachusetts, United States
Total Revenue: $XX Bn
Website: https://www.bostonscientific.com/
Company at a Glance
Company Overview
Sample
32. 32 A Sample Report on Indian Neurology Devices Market I Confidential
7.5 Abbott Laboratories
Company Name: Abbott Laboratories
Year of Establishment: 1888
Headquarter: Chicago, Illinois, United States
Total Revenue: $XX Bn
Website: http://www.abbott.com/
Company at a Glance
Company Overview
Sample
34. 34 A Sample Report on Indian Neurology Devices Market I Confidential
8.1 Policy changes and Reimbursement scenario
Medical device regulation:
▪ Medical devices in India are regulated under the Medical Device Rules, 2017 ("MDR") which only applies to medical devices
specifically notified by the Ministry of Health and Family Welfare ("MoHFW") as regulated medical devices
▪ Once a device is regulated under the MDR, persons engaged in the manufacture, import and sale of medical devices are required
to obtain a license from the relevant drug regulatory authorities to undertake such activities pertaining to the notified medical
devices
Get the report for full access
Reimbursement scenario:
▪ For neurology and neurosurgery, the scheme has several potential benefits. Practically all the significant neuromorbidities requiring
secondary and tertiary care have been covered
▪ Pradhan Mantri Jan Arogya Yojana (PMJAY) covers meningitis, stroke as well as brain tumors and epilepsy surgery. This means
that for 40% Indians, there should be no worry on account of such diseases. Care can be accessed from both private and public
health care facilities. Such strategy would help to create an access to uniform healthcare both for private and public health sector
hospitals
Get the report for full access
36. 36 A Sample Report on Indian Neurology Devices Market I Confidential
9.1 Future Opportunities
▪ Rise in demand for minimally invasive neurosurgical procedures minimally invasive medical procedures offer significant
clinical advantages over conventional surgical procedures, such as shorter hospital stay, faster patient recovery, higher
procedural safety & efficacy, and greater affordability
▪ Thus, the market acceptance and demand for endoscopic and other minimally invasive surgical procedures is growing
among medical professionals
▪ Geriatric individuals are more susceptible to neurological & neurovascular diseases and prefer treatment procedures that
offer easy diagnosis, easy procedures, higher safety, the least possible hospital stay, better efficacy, and reasonable prices
▪ Additionally, aging also increases the incidence of adverse thrombotic events such as pulmonary embolism, stroke, and
epilepsy, which can require neurosurgical interventions. Moreover, arteriovenous malformations also lead to hemorrhages
and seizures, commonly reported among individuals aged 40 years and above
▪ Thus, the rising geriatric population and demand for minimally invasive procedures are expected to offer significant growth
opportunities for prominent as well as emerging market players in the field of neurology devices
Sample
38. 38 A Sample Report on Indian Neurology Devices Market I Confidential
10 Conclusion
1
2
3
5
4
Strong Demand
As there increase in the
incidence and the prevalence of
the neurological diseases, there
is a huge demand for the
neurology devices for its
treatment
Emerging Initiative
Majority of the medical device
companies have started investing
in the research in this area and
have got their new devices
approved which are out there ready
to be used
Availability of Technology
New advance technology and innovation
in neurology device which can be used
to provide increased function for those
with limb loss or congenital limb
differences and other neurological
disorders Insurance coverage for
neurosurgery
Government reimbursement and
private insurance for neurosurgery
under tertiary care is fueling the
market
Advancement in healthcare
delivery
As compared to the past decade
the neurology device has seen
greater and increased sales in past
years which makes it clear that this
area is growing in particular
40. 40 A Sample Report on Indian Neurology Devices Market I Confidential
Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ The currency used in the report is the US dollar (USD), with the market size indicated in USD million/ Bn
41. 41 A Sample Report on Indian Neurology Devices Market I Confidential
Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Interviews
Secondary
Data
Market Trends
Market Sizing
& Analysis
Data Triangulation
& Validation
Analysis &
Interpretation
Insights
Presentation
& Reporting
Data Collection
Market Data Analysis &
Statistical Model
Interpretation and
Presentation
42. 42 A Sample Report on Indian Neurology Devices Market I Confidential
Bottom-up Analysis
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by
Therapeutics &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary
Analysis Methodology
43. 43 A Sample Report on Indian Neurology Device Market Analysis I Confidential
Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
44. 2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period
45. The report is prepared
using a proven
methodology and
insightful research
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com
47. www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust
48. Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com
49. Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices
51. Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com
52. Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com
53. Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
54. Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors . With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team
55. 7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more